Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0 (Q34743442)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0 |
scientific article |
Statements
1 reference
Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0 (English)
1 reference
Gabriel N Hortobagyi
1 reference
Edith A Perez
1 reference
Georgiana K Ellis
1 reference
William E Barlow
1 reference
Julie R Gralow
1 reference
Christy A Russell
1 reference
Melanie E Royce
1 reference
Danika Lew
1 reference
Robert B Livingston
1 reference
10 January 2011
1 reference
1 reference
29
1 reference
8
1 reference
1014-1021
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference